Jeffrey R Curtis

Summary

Affiliation: University of Alabama at Birmingham
Country: USA

Publications

  1. ncbi request reprint Longitudinal patterns in the prevention of osteoporosis in glucocorticoid-treated patients
    Jeffrey R Curtis
    University of Alabama at Birmingham, 35294, USA
    Arthritis Rheum 52:2485-94. 2005
  2. ncbi request reprint Challenges in improving the quality of osteoporosis care for long-term glucocorticoid users: a prospective randomized trial
    Jeffrey R Curtis
    Center for Education and Research on Therapeutics of Musculoskeletal Diseases, University of Alabama at Birmingham, AL 35294, USA
    Arch Intern Med 167:591-6. 2007
  3. doi request reprint Association of infections and tuberculosis with antitumor necrosis factor alpha therapy
    Nivedita M Patkar
    Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, Alabama 35294 3408, USA
    Curr Opin Rheumatol 20:320-6. 2008
  4. ncbi request reprint Estimating effectiveness and cost of biologics for rheumatoid arthritis: application of a validated algorithm to commercial insurance claims
    Jeffrey R Curtis
    Division of Clinical Immunology and Rheumatology, University of Alabama, Birmingham, Alabama Department of Epidemiology, University of Alabama, Birmingham, Alabama Electronic address
    Clin Ther 36:996-1004. 2014
  5. pmc "Design characteristics of the CORRONA CERTAIN study: a comparative effectiveness study of biologic agents for rheumatoid arthritis patients"
    Dimitrios A Pappas
    Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, AL 35294 7201, USA
    BMC Musculoskelet Disord 15:113. 2014
  6. pmc Commentary: the five Ws of a Fracture Liaison Service: why, who, what, where, and how? In osteoporosis, we reap what we sow
    Jeffrey R Curtis
    Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, 510 20th Street South, FOT 802D, Birmingham, AL, 35294, USA
    Curr Osteoporos Rep 11:365-8. 2013
  7. pmc Osteoporosis medication adherence: physician perceptions vs. patients' utilization
    Jeffrey R Curtis
    University of Alabama at Birmingham, FOT 805D, 510 20th Street South, Birmingham, AL 35294, USA
    Bone 55:1-6. 2013
  8. pmc Physicians' explanations for apparent gaps in the quality of rheumatology care: results from the US Medicare Physician Quality Reporting System
    Jeffrey R Curtis
    University of Alabama at Birmingham, AL 35294, USA
    Arthritis Care Res (Hoboken) 65:235-43. 2013
  9. pmc Does medication adherence itself confer fracture protection? An investigation of the healthy adherer effect in observational data
    Jeffrey R Curtis
    University of Alabama at Birmingham, Birmingham, AL 35294, USA
    Arthritis Care Res (Hoboken) 64:1855-63. 2012
  10. pmc Validation of a novel multibiomarker test to assess rheumatoid arthritis disease activity
    Jeffrey R Curtis
    UAB Center for Education and Research on Therapeutics, UAB Arthritis Clinical Intervention Program, Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, FOT 805D, 510 20th Street South, Birmingham, AL 35294, USA
    Arthritis Care Res (Hoboken) 64:1794-803. 2012

Collaborators

Detail Information

Publications122 found, 100 shown here

  1. ncbi request reprint Longitudinal patterns in the prevention of osteoporosis in glucocorticoid-treated patients
    Jeffrey R Curtis
    University of Alabama at Birmingham, 35294, USA
    Arthritis Rheum 52:2485-94. 2005
    ..To evaluate patient and physician factors associated with prevention of glucocorticoid-induced osteoporosis and to describe temporal trends in screening and prevention of glucocorticoid-induced osteoporosis...
  2. ncbi request reprint Challenges in improving the quality of osteoporosis care for long-term glucocorticoid users: a prospective randomized trial
    Jeffrey R Curtis
    Center for Education and Research on Therapeutics of Musculoskeletal Diseases, University of Alabama at Birmingham, AL 35294, USA
    Arch Intern Med 167:591-6. 2007
    ....
  3. doi request reprint Association of infections and tuberculosis with antitumor necrosis factor alpha therapy
    Nivedita M Patkar
    Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, Alabama 35294 3408, USA
    Curr Opin Rheumatol 20:320-6. 2008
    ..We present recent literature on this topic with a focus on clinical applications of this new data...
  4. ncbi request reprint Estimating effectiveness and cost of biologics for rheumatoid arthritis: application of a validated algorithm to commercial insurance claims
    Jeffrey R Curtis
    Division of Clinical Immunology and Rheumatology, University of Alabama, Birmingham, Alabama Department of Epidemiology, University of Alabama, Birmingham, Alabama Electronic address
    Clin Ther 36:996-1004. 2014
    ..The aim of this analysis was to implement a claims-based algorithm to estimate biologic cost per effectively treated patient for biologics approved for moderate to severe rheumatoid arthritis (RA)...
  5. pmc "Design characteristics of the CORRONA CERTAIN study: a comparative effectiveness study of biologic agents for rheumatoid arthritis patients"
    Dimitrios A Pappas
    Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, AL 35294 7201, USA
    BMC Musculoskelet Disord 15:113. 2014
    ..The Comparative Effectiveness Registry to study Therapies for Arthritis and Inflammatory Conditions (CERTAIN) is an ongoing prospective cohort study of adult patients with Rheumatoid Arthritis (RA)...
  6. pmc Commentary: the five Ws of a Fracture Liaison Service: why, who, what, where, and how? In osteoporosis, we reap what we sow
    Jeffrey R Curtis
    Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, 510 20th Street South, FOT 802D, Birmingham, AL, 35294, USA
    Curr Osteoporos Rep 11:365-8. 2013
    ..There are many barriers to implementation which can be addressed. The future of FLS care lies in a collaborative systems-based approach with appropriate stakeholder engagement, leading to seamless integration of osteoporosis care. ..
  7. pmc Osteoporosis medication adherence: physician perceptions vs. patients' utilization
    Jeffrey R Curtis
    University of Alabama at Birmingham, FOT 805D, 510 20th Street South, Birmingham, AL 35294, USA
    Bone 55:1-6. 2013
    ..69, 95% CI: 1.01, 2.85). Overestimation of medication adherence may impede physicians' ability to provide high quality care for their osteoporosis patients...
  8. pmc Physicians' explanations for apparent gaps in the quality of rheumatology care: results from the US Medicare Physician Quality Reporting System
    Jeffrey R Curtis
    University of Alabama at Birmingham, AL 35294, USA
    Arthritis Care Res (Hoboken) 65:235-43. 2013
    ..We described the frequency and nature of physician-reported reasons why recommended care for individual osteoporosis and RA patients was not provided...
  9. pmc Does medication adherence itself confer fracture protection? An investigation of the healthy adherer effect in observational data
    Jeffrey R Curtis
    University of Alabama at Birmingham, Birmingham, AL 35294, USA
    Arthritis Care Res (Hoboken) 64:1855-63. 2012
    ....
  10. pmc Validation of a novel multibiomarker test to assess rheumatoid arthritis disease activity
    Jeffrey R Curtis
    UAB Center for Education and Research on Therapeutics, UAB Arthritis Clinical Intervention Program, Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, FOT 805D, 510 20th Street South, Birmingham, AL 35294, USA
    Arthritis Care Res (Hoboken) 64:1794-803. 2012
    ..We validated a recently developed multibiomarker disease activity (MBDA) test relative to clinical disease activity in diverse RA cohorts...
  11. pmc Factors associated with gastrointestinal perforation in a cohort of patients with rheumatoid arthritis
    Jeffrey R Curtis
    UAB Center for Education and Research on Therapeutics, University of Alabama at Birmingham, FOT 805D, 510 20th Street South, Birmingham, AL 35294, USA
    Arthritis Care Res (Hoboken) 64:1819-28. 2012
    ..To estimate the incidence and risk factors for gastrointestinal (GI) perforation among patients with rheumatoid arthritis (RA)...
  12. pmc Use of a disease risk score to compare serious infections associated with anti-tumor necrosis factor therapy among high- versus lower-risk rheumatoid arthritis patients
    Jeffrey R Curtis
    University of Alabama at Birmingham, Birmingham, AL, USA
    Arthritis Care Res (Hoboken) 64:1480-9. 2012
    ..To evaluate whether rates of serious infection with anti-tumor necrosis factor (anti-TNF) therapy in rheumatoid arthritis (RA) patients differ in magnitude by specific drugs and patient characteristics...
  13. pmc Dyslipidemia and changes in lipid profiles associated with rheumatoid arthritis and initiation of anti-tumor necrosis factor therapy
    Jeffrey R Curtis
    University of Alabama, Birmingham, USA
    Arthritis Care Res (Hoboken) 64:1282-91. 2012
    ..To investigate the frequency of lipid testing in clinical practice and to explore the relationship between rheumatoid arthritis (RA), dyslipidemia, and other cardiovascular (CV) risk factors with RA treatment...
  14. pmc Management of osteoporosis among the elderly with other chronic medical conditions
    Jeffrey R Curtis
    Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, AL 35294, USA
    Drugs Aging 29:549-64. 2012
    ....
  15. pmc Adherence with intravenous zoledronate and intravenous ibandronate in the United States Medicare population
    Jeffrey R Curtis
    University of Alabama at Birmingham, AL, USA
    Arthritis Care Res (Hoboken) 64:1054-60. 2012
    ..To evaluate adherence to drug therapy among new users of zoledronate and intravenous (IV) ibandronate among US Medicare enrollees...
  16. pmc Association of intact parathyroid hormone levels with subsequent hip BMD loss: the Osteoporotic Fractures in Men (MrOS) Study
    Jeffrey R Curtis
    Department of Medicine, Division of Clinical Immunology Rheumatology, University of Alabama at Birmingham, Birmingham, Alabama 35294, USA
    J Clin Endocrinol Metab 97:1937-44. 2012
    ..This association was evaluated in relation to conditions related to higher iPTH [e.g. decreased renal function, low serum 25-hydroxyvitamin D (25[OH]D)]...
  17. pmc Predicting future response to certolizumab pegol in rheumatoid arthritis patients: features at 12 weeks associated with low disease activity at 1 year
    Jeffrey R Curtis
    University of Alabama at Birmingham
    Arthritis Care Res (Hoboken) 64:658-67. 2012
    ..To determine the prognostic significance of data collected early after starting certolizumab pegol (CZP) to predict low disease activity (LDA) at week 52...
  18. pmc Derivation and preliminary validation of an administrative claims-based algorithm for the effectiveness of medications for rheumatoid arthritis
    Jeffrey R Curtis
    Department of Medicine, University of Alabama, 510 20th Street South, FOT 805D, Birmingham, AL 35294, USA
    Arthritis Res Ther 13:R155. 2011
    ..We created and tested a claims-based algorithm to serve as a proxy for the clinical effectiveness of RA medications...
  19. pmc "Pathologic" fractures: should these be included in epidemiologic studies of osteoporotic fractures?
    J R Curtis
    Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, AL, USA
    Osteoporos Int 20:1969-72. 2009
    ..Among these, 48% (vertebral) and 3% (hip) of the fractures were coded as pathologic. Only 25% and 66% of persons with these pathologic fractures had evidence for malignancy...
  20. pmc Elevated liver enzyme tests among patients with rheumatoid arthritis or psoriatic arthritis treated with methotrexate and/or leflunomide
    J R Curtis
    Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, 510 20 Street South, FOT 840, Birmingham, AL 35294, USA
    Ann Rheum Dis 69:43-7. 2010
    ....
  21. pmc Risk of hip fracture after bisphosphonate discontinuation: implications for a drug holiday
    J R Curtis
    Center for Education and Research on Therapeutics of Musculoskeletal Disorders, University of Alabama at Birmingham, Birmingham, AL, USA
    Osteoporos Int 19:1613-20. 2008
    ....
  22. pmc Predicting low disease activity and remission using early treatment response to antitumour necrosis factor therapy in patients with rheumatoid arthritis: exploratory analyses from the TEMPO trial
    Jeffrey R Curtis
    University of Alabama at Birmingham, 35294, USA
    Ann Rheum Dis 71:206-12. 2012
    ....
  23. pmc The geographic availability and associated utilization of dual-energy X-ray absorptiometry (DXA) testing among older persons in the United States
    J R Curtis
    Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, AL, USA
    Osteoporos Int 20:1553-61. 2009
    ..After adjusting for potentially confounding factors, travel distance was strongly associated with DXA testing. Rural residents were most strongly dependent on the availability of DXAs performed in physician offices...
  24. pmc Validation of ICD-9-CM codes to identify gastrointestinal perforation events in administrative claims data among hospitalized rheumatoid arthritis patients
    Jeffrey R Curtis
    Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, FOT 805D, 510 20th Street South, Birmingham, AL 35294, USA
    Pharmacoepidemiol Drug Saf 20:1150-8. 2011
    ..To validate, using physician review of abstracted medical chart data as a gold standard, a claims-based algorithm developed to identify gastrointestinal (GI) perforation cases among rheumatoid arthritis (RA) patients...
  25. pmc Adaptation of Bayesian data mining algorithms to longitudinal claims data: coxib safety as an example
    Jeffrey R Curtis
    Center for Education and Research on Therapeutics of Musculoskeletal Disorders, University of Alabama at Birmingham, Alabama 35294, USA
    Med Care 46:969-75. 2008
    ..Their adaptation for use with longitudinal data such as administrative claims has not been previously evaluated or validated...
  26. pmc Identification and validation of vertebral compression fractures using administrative claims data
    Jeffrey R Curtis
    Center for Education and Research on Therapeutics of Musculoskeletal Disorders, University of Alabama at Birmingham, Birmingham, Alabama 35294, USA
    Med Care 47:69-72. 2009
    ..Vertebral compression fractures (VCFs) are the most common type of osteoporotic fracture. Administrative claims data might be useful to identify VCFs, but this approach to case finding has received limited evaluation...
  27. pmc RisedronatE and ALendronate Intervention over Three Years (REALITY): minimal differences in fracture risk reduction
    J R Curtis
    Center for Education and Research on Therapeutics, University of Alabama at Birmingham, Birmingham, AL, USA
    Osteoporos Int 20:973-8. 2009
    ..We conclude that the agents have comparable efficacy...
  28. pmc Improving the prediction of medication compliance: the example of bisphosphonates for osteoporosis
    Jeffrey R Curtis
    Center for Education and Research on Therapeutics, University of Alabama at Birmingham, Birmingham, Alabama 35294, USA
    Med Care 47:334-41. 2009
    ..We tested whether adding information on compliance with other drugs used to treat chronic, asymptomatic conditions would improve the predictive ability of administrative data to identify adherent individuals...
  29. pmc Validity of physician-reported hospitalized infections in a US arthritis registry
    Jeffrey R Curtis
    Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, 076 Spain Rehabilitation Center, 1717 6th Avenue South, Birmingham, AL 35294 7201, USA
    Rheumatology (Oxford) 48:1269-72. 2009
    ..Using data from the Consortium of Rheumatology Researchers of North America (CORRONA), we evaluated hospitalized infection reports contributed by rheumatologists to establish their validity...
  30. pmc The incidence of gastrointestinal perforations among rheumatoid arthritis patients
    Jeffrey R Curtis
    University of Alabama at Birmingham, Birmingham, AL 35294, USA
    Arthritis Rheum 63:346-51. 2011
    ..This study was undertaken to characterize the incidence and risk factors for GI perforation in RA patients...
  31. pmc Is withholding osteoporosis medication after fracture sometimes rational? A comparison of the risk for second fracture versus death
    Jeffrey R Curtis
    Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, AL 35294, USA
    J Am Med Dir Assoc 11:584-91. 2010
    ..Among US Medicare beneficiaries, we evaluated the risk for second fracture versus death in the 5 years following a hip, clinical vertebral, and wrist/forearm fracture...
  32. pmc A comparison of patient characteristics and outcomes in selected European and U.S. rheumatoid arthritis registries
    Jeffrey R Curtis
    Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, AL, USA
    Semin Arthritis Rheum 40:2-14.e1. 2010
    ..Most registries are either drug based or disease based. These registries include patients with a variety of rheumatic diseases including RA...
  33. pmc The delivery of evidence-based preventive care for older Americans with arthritis
    Jeffrey R Curtis
    Department of Medicine, University of Alabama, Birmingham, Birmingham, AL 35294, USA
    Arthritis Res Ther 12:R144. 2010
    ..We evaluated the proportion of older Americans with RA, psoriatic arthritis (PsA), and osteoarthritis (OA) receiving these services and the specialty of the providers delivering this care...
  34. doi request reprint Dose escalation of certolizumab pegol from 200 mg to 400 mg every other week provides no additional efficacy in rheumatoid arthritis: an analysis of individual patient-level data
    Jeffrey R Curtis
    Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, FOT 805D, 510 20th Street South, Birmingham, Alabama 35294, USA
    Arthritis Rheum 63:2203-8. 2011
    ..To determine whether certolizumab pegol (CZP) dosage escalation from 200 mg to 400 mg every other week benefits some patients with rheumatoid arthritis (RA)...
  35. pmc The comparative risk of serious infections among rheumatoid arthritis patients starting or switching biological agents
    Jeffrey R Curtis
    Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, Alabama, USA
    Ann Rheum Dis 70:1401-6. 2011
    ..This study evaluated the incidence of hospitalised infections among rheumatoid arthritis (RA) patients starting or switching various biological agents...
  36. pmc Physician preference motivates the use of anti-tumor necrosis factor therapy independent of clinical disease activity
    Jeffrey R Curtis
    Center for Education and Research on Therapeutics of Musculoskeletal Disorders, University of Alabama at Birmingham, USA
    Arthritis Care Res (Hoboken) 62:101-7. 2010
    ....
  37. pmc Use of biologics in rheumatoid arthritis: current and emerging paradigms of care
    Jeffrey R Curtis
    University of Alabama at Birmingham, USA
    Clin Ther 33:679-707. 2011
    ..Improved understanding of rheumatoid arthritis (RA) pathogenesis has led to the development of new biologic treatments that target specific elements of RA inflammatory response...
  38. pmc Improving osteoporosis care through multimodal interventions: insights from the University of Alabama at Birmingham Center for Education and Research on Therapeutics
    J R Curtis
    Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Center for Education and Research on Therapeutics on Musculoskeletal Disorders, FOT 805D, 510 20th Street South, Birmingham, AL 35294, USA
    Osteoporos Int 22:445-50. 2011
    ..This article describes evidence implementation as applied to osteoporosis care, drawing from several published or ongoing studies to illustrate challenges and potential solutions in improving the quality of osteoporosis care...
  39. pmc The relationship between bisphosphonate adherence and fracture: is it the behavior or the medication? Results from the placebo arm of the fracture intervention trial
    Jeffrey R Curtis
    Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, AL, USA
    J Bone Miner Res 26:683-8. 2011
    ..Nonrandomized studies of interventions designed to maintain or improve bone density and/or hip fracture may need to consider medication compliance as a confounder to better estimate true intervention effects...
  40. pmc Population-based fracture risk assessment and osteoporosis treatment disparities by race and gender
    Jeffrey R Curtis
    Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham 35294, USA
    J Gen Intern Med 24:956-62. 2009
    ..Undertreatment of osteoporosis has been recognized as a common problem in selected patient subgroups. However, primary prevention has been hampered by limited risk assessment tools that can be applied to large populations...
  41. pmc Do physicians within the same practice setting manage osteoporosis patients similarly? Implications for implementation research
    J R Curtis
    Center for Education and Research on Therapeutics, University of Alabama at Birmingham, Birmingham, AL 35294, USA
    Osteoporos Int 20:1921-7. 2009
    ..We found no significant clustering effect for common practice setting, suggesting that osteoporosis quality improvement (QI) efforts may be able to ignore this factor in designing QI interventions...
  42. pmc Injection-site burning and stinging in patients with rheumatoid arthritis using injectable biologics
    Jeffrey R Curtis
    Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, AL 35294 7201, USA
    Curr Med Res Opin 27:71-8. 2011
    ..This study assessed the prevalence of ISBS and associated comorbidities in patients with RA who receive injectable biologics...
  43. doi request reprint Placebo adherence, clinical outcomes, and mortality in the women's health initiative randomized hormone therapy trials
    Jeffrey R Curtis
    Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, 1530 3rd Ave South, FOT 805D, Birmingham, AL 35294, USA
    Med Care 49:427-35. 2011
    ..We examined associations between adherence to placebo and the risk of fracture, coronary heart disease, cancer, and all-cause mortality in the 2 Women's Health Initiative hormone therapy randomized trials...
  44. pmc Benefit of adherence with bisphosphonates depends on age and fracture type: results from an analysis of 101,038 new bisphosphonate users
    Jeffrey R Curtis
    Center for Education and Research on Therapeutics, University of Alabama at Birmingham, Birmingham, Alabama, USA
    J Bone Miner Res 23:1435-41. 2008
    ..These results provide estimates of absolute fracture effectiveness across age subgroups and fracture types that have been minimally evaluated in clinical trials and may be useful for future cost-effectiveness studies...
  45. ncbi request reprint Prevention and treatment of glucocorticoid-induced osteoporosis
    Jeffrey R Curtis
    University of Alabama at Birmingham, FOT 840, 510 20th Street South, Birmingham, AL 35294, USA
    Curr Osteoporos Rep 5:14-21. 2007
    ..New approaches to evidence implementation are being tested to improve the quality of osteoporosis care and decrease fracture risk among long-term glucocorticoid users...
  46. pmc Regional variation in the denial of reimbursement for bone mineral density testing among US Medicare beneficiaries
    Jeffrey R Curtis
    Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, AL 35294, USA
    J Clin Densitom 11:568-74. 2008
    ..Greater guidance and transparency in coding policies are needed to ensure that DXA as a covered service is reimbursed for Medicare beneficiaries with the appropriate indications...
  47. pmc Longitudinal trends in use of bone mass measurement among older americans, 1999-2005
    Jeffrey R Curtis
    Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, Alabama, USA
    J Bone Miner Res 23:1061-7. 2008
    ..Given the importance of central DXA to assess the risk of osteoporotic fractures, strategies to increase central DXA use to test at-risk persons are warranted...
  48. ncbi request reprint Confirmation of administrative claims-identified opportunistic infections and other serious potential adverse events associated with tumor necrosis factor alpha antagonists and disease-modifying antirheumatic drugs
    J R Curtis
    University of Alabama at Birmingham, Birmingham, Alabama 35294, USA
    Arthritis Rheum 57:343-6. 2007
  49. pmc Rates of hospitalized bacterial infection associated with juvenile idiopathic arthritis and its treatment
    Timothy Beukelman
    University of Alabama at Birmingham, Division of Pediatric Rheumatology, 1600 7th Avenue South, CPP 210, Birmingham, AL 35233 1711, USA
    Arthritis Rheum 64:2773-80. 2012
    ..To compare the incidence of hospitalized bacterial infections among children with and children without juvenile idiopathic arthritis (JIA) and to examine the effects of selected medications...
  50. pmc Brief report: incidence of selected opportunistic infections among children with juvenile idiopathic arthritis
    Timothy Beukelman
    University of Alabama at Birmingham, Division of Pediatric Rheumatology, Birmingham, AL 35233 1711, USA
    Arthritis Rheum 65:1384-9. 2013
    ..To compare incidence rates of selected opportunistic infections among children with and children without juvenile idiopathic arthritis (JIA)...
  51. ncbi request reprint Risk of serious bacterial infections among rheumatoid arthritis patients exposed to tumor necrosis factor alpha antagonists
    Jeffrey R Curtis
    University of Alabama at Birmingham, Center for Education and Research on Therapeutics, AL 35294, USA
    Arthritis Rheum 56:1125-33. 2007
    ..To evaluate the risk of serious bacterial infections associated with tumor necrosis factor alpha (TNFalpha) antagonists among rheumatoid arthritis (RA) patients...
  52. pmc Identifying newly approved medications in Medicare claims data: a case study using tocilizumab
    Jeffrey R Curtis
    University of Alabama at Birmingham, Division of Clinical Immunology and Rheumatology, Birmingham, AL, USA
    Pharmacoepidemiol Drug Saf 22:1214-21. 2013
    ..Accurately identifying these medications is critical to safety and effectiveness research. Methods to identify medications prior to assignment of specific drug codes have not been well described...
  53. pmc Death, debility, and destitution following hip fracture
    Gabriel S Tajeu
    MSPH, School of Public Health, University of Alabama at Birmingham, 1665 University Boulevard, RPHB 330, Birmingham, AL 35294 0022
    J Gerontol A Biol Sci Med Sci 69:346-53. 2014
    ....
  54. pmc Drug-specific and time-dependent risks of bacterial infection among patients with rheumatoid arthritis who were exposed to tumor necrosis factor alpha antagonists
    Jeffrey R Curtis
    University of Alabama at Birmingham, AL, USA
    Arthritis Rheum 56:4226-7. 2007
  55. ncbi request reprint Agreement and validity of pharmacy data versus self-report for use of osteoporosis medications among chronic glucocorticoid users
    Jeffrey R Curtis
    Division of Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, AL, USA
    Pharmacoepidemiol Drug Saf 15:710-8. 2006
    ..However, these data sources have not been previously compared with self-reported data for receipt of medications used for glucocorticoid-induced osteoporosis (GIOP)...
  56. pmc Association between vaccination for herpes zoster and risk of herpes zoster infection among older patients with selected immune-mediated diseases
    Jie Zhang
    Department of Epidemiology, School of Public Health, University of Alabama at Birmingham, 35294, USA
    JAMA 308:43-9. 2012
    ..The safety and effectiveness of the vaccine are unclear for these patients...
  57. pmc Generic alendronate use among Medicare beneficiaries: are Part D data complete?
    Huifeng Yun
    Department of Epidemiology, University of Alabama at Birmingham, Birmingham, AL 35294, USA
    Pharmacoepidemiol Drug Saf 22:55-63. 2013
    ..Medicare beneficiaries might pay for generic alendronate out-of-pocket without having claims submitted, resulting in misclassification of generic alendronate use in Medicare data...
  58. doi request reprint Health services utilization after fractures: evidence from Medicare
    David J Becker
    Department of Health Care Organization and Policy, University of Alabama at Birmingham, 1665 University Blvd, RPHB 330H, Birmingham, AL 35294, USA
    J Gerontol A Biol Sci Med Sci 65:1012-20. 2010
    ..Postfracture utilization of health care services represents an alternative measure of the resource costs associated with these fractures...
  59. pmc The use, safety, and effectiveness of herpes zoster vaccination in individuals with inflammatory and autoimmune diseases: a longitudinal observational study
    Jie Zhang
    Department of Epidemiology, School of Public Health, University of Alabama at Birmingham, 1665 University Blvd, Birmingham, AL 35294, USA
    Arthritis Res Ther 13:R174. 2011
    ....
  60. pmc Rates of malignancy associated with juvenile idiopathic arthritis and its treatment
    Timothy Beukelman
    University of Alabama at Birmingham, Birmingham, AL 35233 1711, USA
    Arthritis Rheum 64:1263-71. 2012
    ..To determine the relative rates of incident malignancy among children with juvenile idiopathic arthritis (JIA) with respect to treatment as compared to children without JIA...
  61. pmc Administrative codes combined with medical records based criteria accurately identified bacterial infections among rheumatoid arthritis patients
    Nivedita M Patkar
    Center for Education and Research on Therapeutics of Musculoskeletal Disorders, University of Alabama at Birmingham, Birmingham, AL 35294 3408, USA
    J Clin Epidemiol 62:321-7, 327.e1-7. 2009
    ..To evaluate diagnostic properties of International Classification of Diseases, Version 9 (ICD-9) diagnosis codes and infection criteria to identify bacterial infections among rheumatoid arthritis (RA) patients...
  62. ncbi request reprint Trends in the utilization and outcomes of Medicare patients hospitalized for hip fracture, 2000-2008
    David J Becker
    University of Alabama at Birmingham, USA
    J Aging Health 26:360-79. 2014
    ..This study examines temporal trends in hip fracture related utilization and outcomes among elderly fee-for-service Medicare beneficiaries...
  63. pmc Thresholds in disease activity for switching biologics in rheumatoid arthritis patients: experience from a large U.S. cohort
    Jie Zhang
    University of Alabama at Birmingham, 35294, USA
    Arthritis Care Res (Hoboken) 63:1672-9. 2011
    ..To examine the threshold in disease activity associated with switching biologic treatment regimens in rheumatoid arthritis (RA) patients in real-world clinical practice...
  64. pmc Changes in lipoproteins associated with methotrexate or combination therapy in early rheumatoid arthritis: results from the treatment of early rheumatoid arthritis trial
    Iris Navarro-Millan
    University of Alabama at Birmingham, Birmingham, AL 35294, USA
    Arthritis Rheum 65:1430-8. 2013
    ....
  65. doi request reprint Recent trends in hip fracture rates by race/ethnicity among older US adults
    Nicole C Wright
    Department of Epidemiology, University of Alabama at Birmingham, Birmingham, AL, USA
    J Bone Miner Res 27:2325-32. 2012
    ..Further research is needed to understand mechanisms responsible for declining rates in some and not others, as hip fractures continue to be a major problem among the elderly...
  66. doi request reprint Central DXA utilization shifts from office-based to hospital-based settings among medicare beneficiaries in the wake of reimbursement changes
    Jie Zhang
    Department of Epidemiology, University of Alabama at Birmingham, Birmingham, AL 35294, USA
    J Bone Miner Res 27:858-64. 2012
    ..The reduction in DXA reimbursement was associated with a decrease in the number of DXAs performed in physician offices and fewer physician offices that provided DXA services...
  67. ncbi request reprint Racial/ethnic disparities in patient-reported nonsteroidal antiinflammatory drug (NSAID) risk awareness, patient-doctor NSAID risk communication, and NSAID risk behavior
    Rachel B Fry
    University of Alabama at Birmingham, Birmingham, AL, USA
    Arthritis Rheum 57:1539-45. 2007
    ..Little is known about NSAID-related ethnic/racial disparities. We focused on differences in patient NSAID risk awareness, patient-doctor NSAID risk communication, and NSAID risk-avoidance behavior...
  68. pmc Management of osteoporosis among home health and long-term care patients with a prior fracture
    Amy H Warriner
    University of Alabama at Birmingham, USA
    South Med J 102:397-404. 2009
    ....
  69. pmc Validation of diagnostic codes for subtrochanteric, diaphyseal, and atypical femoral fractures using administrative claims data
    Pongthorn Narongroeknawin
    Department of Medicine, University of Alabama, Birmingham, AL, USA
    J Clin Densitom 15:92-102. 2012
    ..These claims algorithms will be useful in future population-based observational studies to evaluate associations between osteoporosis medications and subtrochanteric and diaphyseal femoral fractures...
  70. ncbi request reprint Population-based assessment of adverse events associated with long-term glucocorticoid use
    Jeffrey R Curtis
    University of Alabama at Birmingham, 35294, USA
    Arthritis Rheum 55:420-6. 2006
    ..The frequency of many adverse events (AEs) associated with low-dose glucocorticoid use is unclear. We sought to determine the prevalence of glucocorticoid-associated AEs in a large US managed care population...
  71. doi request reprint Health care expenditures associated with skeletal fractures among Medicare beneficiaries, 1999-2005
    Meredith L Kilgore
    Department of Health Care Organization and Policy, University of Alabama at Birmingham, Birmingham, Alabama, USA
    J Bone Miner Res 24:2050-5. 2009
    ..Further research is needed to ascertain other health conditions that are driving costs for Medicare beneficiaries after fractures...
  72. ncbi request reprint Osteoporosis in the home health care setting: A window of opportunity?
    Jeffrey R Curtis
    University of Alabama at Birmingham, Birmingham, AL 35294, USA
    Arthritis Rheum 55:971-5. 2006
  73. pmc Biologics and heart failure in rheumatoid arthritis: are we any wiser?
    Maria I Danila
    Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, Alabama, USA
    Curr Opin Rheumatol 20:327-33. 2008
    ....
  74. pmc Geographic distribution of endemic fungal infections among older persons, United States
    John W Baddley
    University of Alabama at Birmingham, Birmingham, AL35294 0006, USA
    Emerg Infect Dis 17:1664-9. 2011
    ..1%) cases, there was no patient exposure to a traditional disease-endemic area. Knowledge of areas where endemic mycosis incidence is increased may affect diagnostic or prevention measures for older adults at risk...
  75. doi request reprint Osteoporosis care in the United States after declines in reimbursements for DXA
    Burton L Hayes
    Department of Medicine, University of Tennessee Health Science Center, Memphis, TN, USA
    J Clin Densitom 13:352-60. 2010
    ....
  76. ncbi request reprint Treatment of rheumatoid arthritis
    Angelo Gaffo
    Center for Education and Research and Therapeutics of Musculoskeletal Diseases, University of Alabama at Birmingham, Birmingham, AL, USA
    Am J Health Syst Pharm 63:2451-65. 2006
    ..Current and investigational treatments of rheumatoid arthritis (RA) are described...
  77. pmc Improving osteoporosis care in high-risk home health patients through a high-intensity intervention
    Ryan C Outman
    Department of Medicine, Division of Immunology and Rheumatology, University of Alabama at Birmingham, FOT 820, 1530 3rd Ave S, Birmingham, AL 35294, United States
    Contemp Clin Trials 33:206-12. 2012
    ..We developed and tested a multi-modal intervention, delivered in the home health care setting, aimed at increasing osteoporosis treatment rates to prevent fractures...
  78. doi request reprint Which fractures are most attributable to osteoporosis?
    Amy H Warriner
    Division of Endocrinology, Metabolism and Diabetes, The University of Alabama at Birmingham, Birmingham, AL 35233, USA
    J Clin Epidemiol 64:46-53. 2011
    ..Determining anatomic sites and circumstances under which a fracture may be a consequence of osteoporosis is a topic of ongoing debate and controversy that is important to both clinicians and researchers...
  79. doi request reprint The epidemiology of glucocorticoid-associated adverse events
    Allyson K McDonough
    Division of Clinical Immunology and Rheumatology, Department of Medicine, University of Alabama at Birmingham, 510 20th Street South, Birmingham, AL 35213, USA
    Curr Opin Rheumatol 20:131-7. 2008
    ..The purpose of this review is to provide an update on the most recent literature regarding glucocorticoid use and associated adverse events...
  80. ncbi request reprint Trends in prevention of glucocorticoid-induced osteoporosis
    Kenneth G Saag
    UAB Center for Education and Research on Musculoskeletal Disorders, University of Alabama at Birmingham, 35294, USA
    J Rheumatol 33:1651-7. 2006
    ..To determine longitudinal patterns and predictors for the utilization of bone mass measurements and anti-osteoporotic medications in the prevention of glucocorticoid-induced osteoporosis...
  81. pmc Adherence to osteoporosis treatments: room for improvement
    Amy H Warriner
    Division of Endocrinology and Metabolism, University of Alabama at Birmingham, Birmingham, Alabama, USA
    Curr Opin Rheumatol 21:356-62. 2009
    ..Poor adherence leads to reduced effectiveness, increased morbidity, and increased medical costs...
  82. pmc Bisphosphonate-associated osteonecrosis of the jaw, with healing after teriparatide: a review of the literature and a case report
    Pongthorn Narongroeknawin
    Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, AL, USA
    Spec Care Dentist 30:77-82. 2010
    ..ONJ is a serious but infrequent condition that has been recently associated with nitrogen-containing bisphosphonate therapy. Teriparatide may be a useful adjunctive therapy when ONJ develops...
  83. ncbi request reprint Mortality and cancer incidence among tire manufacturing workers hired in or after 1962
    Colleen Beall
    Department of Epidemiology, University of Alabama at Birmingham, Bermingham, AL 35294 0022, USA
    J Occup Environ Med 49:680-90. 2007
    ..This study evaluated mortality during 1962 through 2003 and cancer incidence during 1995 through 2003 at a tire manufacturing plant...
  84. ncbi request reprint Historical estimation of exposure to 1,3-butadiene, styrene, and dimethyldithiocarbamate among synthetic rubber workers
    Maurizio Macaluso
    Department of Epidemiology, School of Public Health, University of Alabama at Birmingham, AL, USA
    J Occup Environ Hyg 1:371-90. 2004
    ..Nevertheless, the new exposure estimates were highly correlated with the old, yielding equivalent exposure ranking of workers and were comparable to limited industrial hygiene data published by NIOSH...
  85. doi request reprint Official Positions for FRAX® clinical regarding international differences from Joint Official Positions Development Conference of the International Society for Clinical Densitometry and International Osteoporosis Foundation on FRAX®
    Jane A Cauley
    Department of Epidemiology, University of Pittsburgh, PA, USA
    J Clin Densitom 14:240-62. 2011
    ..The statements approved by the panel of experts are discussed in the current paper...
  86. ncbi request reprint Medication errors with the use of allopurinol and colchicine: a retrospective study of a national, anonymous Internet-accessible error reporting system
    Ted R Mikuls
    Department of Medicine, University of Nebraska Medical Center, Omaha, USA
    J Rheumatol 33:562-6. 2006
    ..To more closely assess medication errors in gout care, we examined data from a national, Internet-accessible error reporting program over a 5-year reporting period...
  87. ncbi request reprint A group randomized trial to improve safe use of nonsteroidal anti-inflammatory drugs
    Jeffrey R Curtis
    Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, Alabama 35294, USA
    Am J Manag Care 11:537-43. 2005
    ....
  88. doi request reprint American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis
    Kenneth G Saag
    University of Alabama, Birmingham, AL, USA
    Arthritis Rheum 59:762-84. 2008
  89. ncbi request reprint Improving quality of care in osteoporosis: opportunities and challenges
    Gim Gee Teng
    Center for Education and Research on Therapeutics CERTs of Musculoskeletal Disorders, Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, 820 Faculty Office Tower, 510 20th Street South, Birmingham, AL 35294 3708, USA
    Curr Rheumatol Rep 10:123-30. 2008
    ..Recent studies have indicated that restructuring care at the system level is more likely to be successful, dependable, and durable than traditional quality improvement interventions focusing predominantly on physicians...
  90. ncbi request reprint Quality health care gaps in osteoporosis: how can patients, providers, and the health system do a better job?
    Gim Gee Teng
    Center for Education and Research on Therapeutics of Musculoskeletal Disorders, and Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, 510 20th Street South, Birmingham, AL 35294 3708, USA
    Curr Osteoporos Rep 7:27-34. 2009
    ..Methods to improve quality of care in osteoporosis need to be multipronged, with emphasis on clinical process improvement and reliance on interdisciplinary teams. We review the growing literature on quality of care for osteoporosis...
  91. ncbi request reprint Swallowing difficulties from "DISH-phagia"
    Jeffrey R Curtis
    Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, 510 20th Street South, Birmingham, AL 35294, USA
    J Rheumatol 31:2526-7. 2004
  92. ncbi request reprint 1,3-Butadiene and leukemia among synthetic rubber industry workers: exposure-response relationships
    Hong Cheng
    University of Alabama at Birmingham, Ryals School of Public Health, Department of Epidemiology, Birmingham, AL, USA
    Chem Biol Interact 166:15-24. 2007
    ..The present results support the presence of a causal relationship between high cumulative exposure and high intensity of exposure to BD and leukemia...
  93. ncbi request reprint TCDD exposure-response analysis and risk assessment
    Hong Cheng
    Department of Epidemiology, School of Public Health, University of Alabama at Birmingham, USA
    Risk Anal 26:1059-71. 2006
    ....
  94. ncbi request reprint Validation of 1,3-butadiene exposure estimates for workers at a synthetic rubber plant
    Nalini Sathiakumar
    Department of Epidemiology, University of Alabama at Birmingham School of Public Health, Birmingham, AL 35294 0022, USA
    Chem Biol Interact 166:29-43. 2007
    ..The estimates were developed without using historical measurement data and have not been validated previously...
  95. ncbi request reprint Mortality among triazine herbicide manufacturing workers
    Paul A MacLennan
    School of Public Health, Department of Epidemiology and International Health, University of Alabama at Birmingham, 533 Ryals Building, 1665 University Boulevard, Birmingham, AL 35294 0022, USA
    J Toxicol Environ Health A 66:501-17. 2003
    ..It did not provide evidence that employment in triazine herbicide manufacturing and formulating operations was associated causally with overall or cause-specific mortality...
  96. ncbi request reprint Cancer incidence among triazine herbicide manufacturing workers
    Paul A MacLennan
    Department of Epidemiology and International Health, School of Public Health, University of Alabama at Birmingham, Birmingham, Alabama
    J Occup Environ Med 44:1048-58. 2002
    ..There is no epidemiologic or other information that clearly supports a causal relation between atrazine and prostate cancer...
  97. ncbi request reprint Styrene and ischemic heart disease mortality among synthetic rubber industry workers
    Elizabeth Delzell
    Department of Epidemiology, University of Alabama at Birmingham, Birmingham, Alabama 35294 0022, USA
    J Occup Environ Med 47:1235-43. 2005
    ..We examined the relation between styrene and ischemic heart disease (IHD) mortality among 16,579 men in the synthetic rubber industry...
  98. ncbi request reprint Mortality among semiconductor and storage device-manufacturing workers
    Colleen Beall
    Department of Epidemiology, University of Alabama at Birmingham, AL 35294 0022, USA
    J Occup Environ Med 47:996-1014. 2005
    ..We evaluated mortality during 1965 to 1999 among 126,836 workers at two semiconductor facilities and one storage device facility...
  99. ncbi request reprint Methodologic issues in follow-up studies of cancer incidence among occupational groups in the United States
    Thomas J Bender
    Department of Epidemiology, School of Public Health, University of Alabama at Birmingham, Birmingham, AL 35294, USA
    Ann Epidemiol 16:170-9. 2006
    ..This article describes procedures for addressing these challenges...
  100. ncbi request reprint Mortality among hourly motor vehicle manufacturing workers
    Elizabeth Delzell
    Department of Epidemiology and International Health, University of Alabama at Birmingham, Birmingham, AL 35294, USA
    J Occup Environ Med 45:813-30. 2003
    ..Further information on employees' occupational exposures and personal attributes is required to clarify the interpretation of these results...

Research Grants4

  1. Longitudinal Comparative Effectiveness & Safety of Biologics in Autoimmunity
    Jeffrey R Curtis; Fiscal Year: 2010
    ....
  2. Ethnic Differences in the Risk of Fracture and Vascular Disease
    Jeffrey Curtis; Fiscal Year: 2007
    ..Beyond the training objective of this award, the ultimate goal is better prevention through improved identification of those at highest risk for poor outcomes from osteoporotic fractures and associated vascular disease. ..
  3. Longitudinal Comparative Effectiveness & Safety of Biologics in Autoimmunity
    Jeffrey Curtis; Fiscal Year: 2009
    ....